Ajay Major/LinkedIn
Jun 20, 2025, 13:45
Ajay Major: MALIBU R + Ibrutinib in 1L Advanced Stage ENZML
Ajay Major, Assistant Professor of Medicine at the University of Colorado School of Medicine, shared a post on X:
“MALIBU R + ibrutinib in 1L adv-stage ENZML
126 pts, all int/high MALT-IPI risk
BOR 62%, 3-yr PFS 72%, OS 93%
15% Gr3+ afib
Max 2 yrs of ibrutinib, but relatively toxic. 2nd gen BTKi better?”
More posts featuring Ajay Major.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 9, 2025, 17:59
Jul 9, 2025, 17:48
Jul 9, 2025, 17:21
Jul 9, 2025, 17:11
Jul 9, 2025, 17:09
Jul 9, 2025, 16:50
Jul 9, 2025, 16:44